To support organizations in the tourism sector and prepare them for an eventual recovery, the Government of Canada will announce financial assistance in several regions across Quebec on January 18 and 19, 2021.
The Honourable Mélanie Joly, Minister of Economic Development and Official Languages, invites media representatives to a press conference on support for Refuge Pageau (legal name: Centre des marais et ses habitants inc.), Festival des guitares du monde en Abitibi-Témiscamingue (Festivals illimités) as well as the Ville d'Amos.
Tourism is a major economic engine in Quebec generating many jobs. This sector was hit hard due to the COVID-19 pandemic and the impacts could last several months, and even years.
Date: January 18, 2021
Time: 9:00 a.m.
The press briefing will be held online through the Zoom platform.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
